Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02163525Not ApplicableCompleted

Post Market TRUST - U.S.A. Study

Role: lead

NCT01563783Not ApplicableCompleted

Post Market TRUST Study

Role: lead

NCT01750008Not ApplicableCompleted

Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions

Role: lead

NCT01842789Not ApplicableTerminated

Post Market Evaluation of Acessa With TAG

Role: lead

NCT00874029Not ApplicableCompleted

Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids

Role: lead

All 5 trials loaded